Laronidase News
Laronidase currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Laronidase with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Aldurazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis I (MPS I; alpha-L-iduronidase deficiency) to treat the nonneurological...
- Evidence level: L5
- Predicted indications (20):
- Scheie syndrome (99.7%)
- lysosomal storage disease with skeletal involvement (99.3%)
- Hurler syndrome (99.2%)
- Sanfilippo syndrome (99.2%)
- lysosomal disease with hypertrophic cardiomyopathy (98.8%)
- syndromic neurometabolic disease with X-linked intellectual disability (98.7%)
- eyelids malposition disorder (98.7%)
- camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye (98.6%)
- ptosis-strabismus-ectopic pupils syndrome (98.6%)
- inborn disorder of lysosomal amino acid transport (98.6%)
- ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome (98.6%)
- ptosis-vocal cord paralysis syndrome (98.5%)
- congenital Horner syndrome (disease) (98.5%)
- Steel syndrome (98.5%)
- Hurler-Scheie syndrome (98.4%)
- jaw-winking syndrome (98.4%)
- congenital entropion (98.3%)
- epiblepharon (98.2%)
- mucopolysaccharidosis (98.2%)
- congenital ectropion (98.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.